The Nuclear Medicine Market, in terms of revenue, was valued at US$ 4.62 Bn in 2020 and is expected to reach US$ 6.81 Bn by 2030. Absolute Markets insights added an erudite statistical report to its extensive database titled Nuclear Medicine Market. This expansive market study applies primary and secondary research techniques. The analytical report also presents various key aspects responsible for shaping the future of the businesses. It further also offers several approaches for augmenting the growth of the customers frequently. The recent market research report provides insightful knowledge about the global Nuclear Medicine market. Researchers further also draw attention to the current market scenario, historical records as well as predictions of the market growth in the near future.
Some of the key participants of global nuclear medicine market are Cardinal Health, Inc., Medtronic, Minimally Invasive Therapies, Ion Beam Applications S.A (IBA Worldwide), Lantheus Medical Imaging Inc., General Electric Company, Bracco Imaging S.p.A, Bayer AG, Advanced Medical Isotope Corporation, Alliance Medical Limited, Alseres Pharmaceuticals, Inc., Avid Radiopharmaceuticals, Inc., Actinium Pharmaceuticals, Inc., Immunomedics, Inc., Jubilant Pharma LLC, Mallinckrodt Pharmaceuticals, Medi-Radiopharma Co., Ltd., Peregrine Pharmaceuticals, Inc. and Positron Corporation, Nordion (Canada) Inc. amongst others.
Browse the Full Report: https://www.absolutemarketsinsights.com/reports/Nuclear-Medicine-Market-2018-2026-32
Global market based on the product type is classified as diagnostic medicine and therapeutic medicine. In the diagnosis, there are two types of imaging techniques which includes, single-photon emission computed tomography (SPECT) and positron emission tomography (PET). These techniques are very helpful in diagnosis of gall bladder disease, thyroid disease, cancer, Alzheimer’s disease, heart conditions and brain conditions. The diagnostic medicine held the largest share in global nuclear medicine market and is also anticipated to be the fastest growing market in terms of the CAGR. The growing importance of diagnosis of fatal diseases among people, has driven the diagnostic medicine segment.
In the global market, North America is expected to be the leading market during the forecast period. The United States has shown substantial growth in the North America region. This growth is mainly attributed to the advancement in technology such as the development of molecular imaging based on the tracer principle, the introduction of new radiopharmaceuticals for diagnosis and therapy and hybrid imaging. The Europe and Asia Pacific areas account for noteworthy shares in the nuclear medicine market.
Market Segmentation:
Product Outlook
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- Therapeutic Products
- Alpha Emitters
- RA-223
- Other alpha emitters
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- SPECT
Application Outlook
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
Contact Us:
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91-7400-24-24-24, US +1-510-420-1213
Website: www.absolutemarketsinsights.com
